Why Vyvanse became the internet's favorite ADHD medication and what patients and prescribers should actually understand about it.
Jonathan Murphy, PMHNP-BC, walks through the pharmacology, the Reddit hype cycle, and how Vyvanse fits into the real optimization pathway.
This episode covers:
Why extended-release stimulants became first-line and how insurance approval finally caught up to clinical reality
The two stimulant chemicals: amphetamine and methylphenidate, and why roughly half of adults respond best to one over the other
What "zombification" on methylphenidate signals and what "tweaking out" on amphetamine signals
Why Adderall XR gets prescribed first most of the time and what that pathway leads to
The Vyvanse pharmacology: lisdexamfetamine as a prodrug that converts in the bloodstream to dextroamphetamine
The dextro versus levo amphetamine distinction: dextro for the brain, levo for the peripheral nervous system
Why Vyvanse feels like a smoother ride for patients who don't tolerate the levoamphetamine in Adderall XR
The Reddit dynamic that keeps positioning Vyvanse as the best ADHD medication and why that framing distorts optimization
The Dexedrine Spansule as the older, cheaper alternative that does essentially the same thing pharmacologically
Why "all good, no bad" is the standard, not "good enough"
The big four extended-release stimulants: Adderall XR, Vyvanse, extended-release methylphenidate (Ritalin LA or Concerta), and Focalin
Why there is no best ADHD medication, only the right medication for your brain
This is the thirteenth episode of Actually ADHD.
The book The Process: An Adult's Guide to ADHD Medication is available on Amazon: https://www.amazon.com/dp/B0H2Z6PM4T
For educational purposes only. Not medical advice. Consult your own provider for clinical decisions.